Technical Analysis for NRXP - NeuroRx, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
20 DMA Support | Bullish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
NR7 | Range Contraction | -2.34% | |
Narrow Range Bar | Range Contraction | -2.34% | |
Inside Day | Range Contraction | -2.34% | |
Pocket Pivot | Bullish Swing Setup | -2.34% | |
Wide Bands | Range Expansion | -2.34% | |
NR7 | Range Contraction | -0.79% | |
Wide Bands | Range Expansion | -0.79% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
50 DMA Support | about 20 hours ago |
Down 5% | about 20 hours ago |
Fell Below 50 DMA | about 20 hours ago |
Fell Below Previous Day's Low | about 20 hours ago |
60 Minute Opening Range Breakdown | about 20 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/14/2022
NeuroRx, Inc. operates as a clinical stage-small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders. Its drug candidate includes Cyclurad, an oral therapeutic for the treatment of acute/elevated suicidal ideation/crisis in bipolar depression. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Sector: Industrials
Industry: Conglomerates
Keywords: Life Sciences Health Sciences Health Care Central Nervous System Disorders Antidepressants Bipolar Disorder Treatment Of Central Nervous System Disorders Atypical Antipsychotics Bipolar Depression
Classification
Sector: Industrials
Industry: Conglomerates
Keywords: Life Sciences Health Sciences Health Care Central Nervous System Disorders Antidepressants Bipolar Disorder Treatment Of Central Nervous System Disorders Atypical Antipsychotics Bipolar Depression
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.54 |
52 Week Low | 0.4899 |
Average Volume | 410,117 |
200-Day Moving Average | 0.98 |
50-Day Moving Average | 1.21 |
20-Day Moving Average | 1.23 |
10-Day Moving Average | 1.29 |
Average True Range | 0.10 |
RSI | 51.92 |
ADX | 23.53 |
+DI | 18.67 |
-DI | 15.39 |
Chandelier Exit (Long, 3 ATRs) | 1.11 |
Chandelier Exit (Short, 3 ATRs) | 1.34 |
Upper Bollinger Bands | 1.40 |
Lower Bollinger Band | 1.06 |
Percent B (%b) | 0.56 |
BandWidth | 27.80 |
MACD Line | 0.03 |
MACD Signal Line | 0.03 |
MACD Histogram | -0.0018 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.37 | ||||
Resistance 3 (R3) | 1.37 | 1.32 | 1.35 | ||
Resistance 2 (R2) | 1.32 | 1.29 | 1.33 | 1.34 | |
Resistance 1 (R1) | 1.29 | 1.27 | 1.27 | 1.29 | 1.34 |
Pivot Point | 1.24 | 1.24 | 1.23 | 1.25 | 1.24 |
Support 1 (S1) | 1.21 | 1.21 | 1.19 | 1.21 | 1.16 |
Support 2 (S2) | 1.16 | 1.19 | 1.17 | 1.16 | |
Support 3 (S3) | 1.13 | 1.16 | 1.15 | ||
Support 4 (S4) | 1.13 |